News from aeterna zentaris inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 25, 2015, 13:00 ET Aeterna Zentaris Affirms Fundamental Strength of Business

QUEBEC CITY, Nov. 25, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), affirms that its business and prospects remain fundamentally strong and highlights the...

Nov 24, 2015, 11:30 ET Aeterna Zentaris Confirms No Corporate Developments

QUEBEC CITY, Nov. 24, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), at the request of IIROC on behalf of the Toronto Stock Exchange, confirms that as of the...

Nov 24, 2015, 08:30 ET Aeterna Zentaris Announces Exercise of Last Series B Warrants Covered by November 1, 2015 Agreement

QUEBEC CITY, Nov. 24, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced today that the remaining 11,000 post-share consolidation (or 1,100,000 pre-share...

Nov 19, 2015, 08:30 ET Aeterna Zentaris Announces First Patient Enrolled for Confirmatory Phase 3 Trial of Macrilen™ for the evaluation of AGHD

QUEBEC CITY, Nov. 19, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS)(TSX: AEZ) (the "Company") announced today that the first patient has been enrolled for the Company's confirmatory Phase...

Nov 18, 2015, 08:30 ET Aeterna Zentaris Announces Details and Implementation of Share Consolidation to Regain NASDAQ Compliance

Common shares to begin trading on a consolidated and reverse-split-adjusted basis on November 20, 2015 QUÉBEC CITY, Nov. 18, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the...

Nov 16, 2015, 11:44 ET Aeterna Zentaris Announces Shareholder Approval of Share Consolidation

QUÉBEC CITY, Nov. 16, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the holders of its issued and outstanding common shares ("Common...

Nov 12, 2015, 12:54 ET Aeterna Zentaris Announces Exercise of Series B Warrants

QUEBEC CITY, Nov. 12, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced today that 1,906,451 Series B Common Share Purchase Warrants (the "Series B...

Nov 11, 2015, 08:30 ET Aeterna Zentaris Urges Shareholders to Vote in Favor of the Share Consolidation and Highlights Support from ISS and Glass Lewis

All amounts are in US Dollars QUEBEC CITY, Nov. 11, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today urged its shareholders to vote FOR a special resolution...

Nov 05, 2015, 17:00 ET Aeterna Zentaris Reports Third Quarter Financial and Operating Results

Strong fundamentals; dilution from Series B Warrants substantially ended All amounts are in US Dollars Third quarter key developments Saizen® promotional activities show early promise EstroGel®...

Nov 02, 2015, 09:30 ET Aeterna Zentaris Announces Agreement to Exercise Substantially All Remaining Series B Warrants

All references to dollars are to United States dollars QUEBEC CITY, Nov. 2, 2015 /CNW/ - Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company") announced today that the holders (the...

Oct 27, 2015, 08:30 ET Leading Independent Advisory Firms ISS and Glass Lewis Recommend Shareholders of Aeterna Zentaris Vote FOR Share Consolidation

QUEBEC CITY, Oct. 27, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that Institutional Shareholder Services Inc. (ISS) and Glass Lewis & Co., two ...

Oct 23, 2015, 15:00 ET Aeterna Zentaris to Announce Third Quarter 2015 Financial and Operating Results on November 6, 2015

QUEBEC CITY, Oct. 23, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its third quarter 2015 financial and operating results on Friday, November 6,...

Oct 16, 2015, 07:30 ET Aeterna Zentaris Announces Special Meeting of Shareholders and Mailing of Management Information Circular

QUEBEC CITY, Oct. 16, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Corporation") today announced that it has convened a special meeting of shareholders (the "Meeting") to ...

Oct 13, 2015, 07:30 ET Aeterna Zentaris: Data and Safety Monitoring Board Recommends Continuation of ZoptEC Phase 3 Trial in Advanced Endometrial Cancer

DSMB's recommendation follows 2nd interim efficacy and safety analysis QUEBEC CITY, Oct. 13, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that...

Oct 12, 2015, 08:26 ET Aeterna Zentaris Announces Restructuring of Finance & Accounting Operations and Closure of Quebec City Office

QUEBEC CITY, Oct. 12, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a specialty biopharmaceutical company engaged in developing and commercializing novel...

Sep 28, 2015, 11:00 ET Aeterna Zentaris' Zoptarelin Doxorubicin Meets Phase 2 Primary Endpoint in Men with Heavily Pretreated Castration and Taxane Resistant Prostate Cancer

QUEBEC CITY, Sept. 28, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its lead oncology compound, zoptarelin doxorubicin (formerly AEZS‑108), ...

Sep 25, 2015, 16:30 ET Aeterna Zentaris Announces TSX Approval of Series B Warrant Amendment

All amounts are in US dollars QUEBEC CITY, Sept. 25, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company") announced today that The Toronto Stock Exchange ("TSX") has...

Sep 24, 2015, 09:00 ET Aeterna Zentaris Announces Dismissal of Class Action Lawsuit

QUEBEC CITY, Sept. 24, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company"), announced today that the previously disclosed purported class action lawsuit filed against...

Sep 21, 2015, 09:00 ET Aeterna Zentaris Announces Amendment to Series B Warrants

All amounts are in US dollars QUEBEC CITY, Sept. 21, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS)(TSX: AEZ) (the "Company") announced today that it has entered into definitive agreements...

Sep 03, 2015, 07:30 ET Aeterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New York

QUÉBEC CITY, Sept. 3, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the Company's Chief Financial Officer, Dennis Turpin, will be presenting ...

Aug 13, 2015, 16:15 ET Aeterna Zentaris Reports Second Quarter Financial and Operating Results

Strong fundamentals; pace of transformation accelerates; dilution negatively impacts stock price All amounts are in US Dollars Second quarter key developments Data and Safety Monitoring Board...

Aug 11, 2015, 07:30 ET Aeterna Zentaris Announces Data and Safety Monitoring Board Scheduled to Complete Second Interim Analysis of the ZoptEC Phase 3 Trial in Endometrial Cancer in Early October

QUEBEC CITY, Aug. 11, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the independent Data and Safety Monitoring Board ("DSMB") for the...

Aug 06, 2015, 07:30 ET Aeterna Zentaris to Announce Second Quarter 2015 Financial and Operating Results on August 13, 2015

QUEBEC CITY, Aug. 6, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its second quarter 2015 financial and operating results after market close on...

Aug 04, 2015, 07:30 ET Aeterna Zentaris to Present at Upcoming Canaccord Genuity 35th Annual Global Growth Conference in Boston

QUÉBEC CITY, Aug. 4, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the Company's Chairman and CEO, David Dodd, will be presenting a...

Jul 29, 2015, 07:30 ET Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development

QUEBEC CITY, July 29, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced it has selected an optimized Erk inhibitor molecule for development, thus...